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Profound Peripheral T-Lymphocyte Depletion and Activation in Disseminated Tuberculosis
Denise Silva Rodrigues, Reinaldo Salomão Infectious Diseases Division, Federal University of
and Esper Georges Kallas São Paulo; São Paulo, SP, Brazil
Three HIV-1-seronegative patients with disseminated tuberculosis presented significant depletion
of T-cell counts, in CD
4
+ and/or CD
8
+ cells, associated with increased expression of activation marker
CD
38
 on CD
8
+ T-lymphocytes. This finding raises the question of potential mechanisms involved in
the activation or loss of T-cells in disseminated tuberculosis.
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Tuberculosis is a major global public health problem and
is still one of the leading causes of infectious-disease-related
deaths. A better understanding of the mechanisms governing
the host reaction to the causative pathogen and disease
control is fundamental for the development of new and more
immunogenic vaccines and adjunctive therapies.
It is known that the cellular immune response, particularly
that produced by T-lymphocytes, plays a central role in
controlling Mycobacterium tuberculosis replication [1, 2]. The
immune response after M. tuberculosis infection and disease
may be visualized by the measurement of T-lymphocyte
phenotypes in human peripheral blood. Diminished numbers
of CD
4
+ and CD
8
+ T-cells have been described in patients with
active tuberculosis [3-6]. Since defense against M.
tuberculosis depends on the efficacy of cell-mediated
immunity, it is important to unravel its mechanisms [1,2,7].
In a previous study, lower CD
4
+ and CD
8
+ T-lymphocyte
counts were found in patients with active disease. Expanded
immunophenotyping demonstrated the loss of both naïve and
memory/effector subpopulations of CD
4
+ T-lymphocytes, and
increased CD
8
+ T-lymphocyte activation [8]. Here we report a
profound depletion in T-cells subpopulations in patients with
severe tuberculosis, in the absence of other identifiable causes
of immunodeficiency.
Written informed consent was obtained from all the
participants or from their legal representative, according to
the guidelines of the Brazilian Ministry of Health. Three
patients with disseminated tuberculosis were identified in the
Infectious Diseases ward of the Hospital São Paulo, of the
Federal University of São Paulo. Cases were defined by a
medical history, clinical findings, and image studies compatible
with miliary tuberculosis, or when multiorgan involvement
was detected. Tuberculosis diagnosis was confirmed by the
presence of at least one positive sputum smear for acid-fast
bacilli or the growth of M. tuberculosis in a biological sample.
A flow cytometric assay was performed using a four-
color staining panel of the conjugated antibodies: HLA-
DR fluorescein isothiocyanate (FITC, clone L243), CD
27
phycoerythrin (PE, clone L128), CD
45
RA FITC (clone L48),
CD
8
 peridin chlorophyll protein (PerCP, clone SK1), CD
4
PerCP (clone SK3), and CD
3
 allophycocyanin (APC, clone
UCHT1), monoclonal antibodies (BD Biosciences, San Jose,
CA), and CD
38
 FITC (clone HIT2, Pharmingen, San Diego,
CA). Briefly, 100µL of EDTA-treated blood was incubated
at room temperature with a combination of monoclonal
antibodies for 15 minutes in the dark, and then treated with
lysing buffer for a further 10 minutes. Cells were washed
and resuspended in phosphate saline buffer supplemented
with 1% sodium azide for cytometric analysis. To obtain
blood T-CD
4
+ and CD
8
+ lymphocyte absolute counts, a
TriTest and TrueCount reagent kit (BD Biosciences) was
used according to the manufacturer’s instructions.
The subpopulation of naïve, effector, and memory cells
was analyzed as a function of the absolute number and
percentage of cells expressing different combinations of
CD
45
RA and CD
27
 on the CD
4
+ T-lymphocytes. The
activation of CD
8
+ T-lymphocytes was determined by
surface expression of the CD
38
 molecule.
Three cases of HIV-negative patients with disseminated
tuberculosis and pulmonary involvement were available
for analysis. They had no other underlying disease and no
history of immunosuppressive therapy.
Patient 1: A 51 year-old man presented with two months of
symptoms of respiratory disease. He complained of chest
pain, shortness of breath, and cough with productive
sputum, together with four months of progressive weight
loss, weakness, and intermittent fever. On physical
examination the patient appeared ill and cachectic.
Superficial cervical lymph nodes were palpable. Miliary
infiltrates in a frontal chest roentgenogram suggested
hematogenic dissemination of M. tuberculosis. Acid-fast
bacilli were found in the sputum smear, and granulomas
were found in a lymph node biopsy. The CD
4
+ and CD
8
+ T-
lymphocytes counts were 186 cells/µL and 152 cells/µL,
respectively.
Patient 2: A 50 year-old woman was hospitalized presenting
severe respiratory involvement. She described a two-
www.bjid.com.br
60 BJID 2006; 10 (February)
months of weight loss and had recently developed severe
respiratory failure. A chest roentgenogram demonstrated
typical miliary lesions. Acid-fast bacilli were found in the
sputum smear. Her CD
4
+ and CD
8
+ T-lymphocyte counts
were 59 cells/µL and 43 cells/µL, respectively. She died a
few days after hospital admittance.
Patient 3: A 31 year-old man was admitted with a history of
weight loss and productive cough during the previous three
months. He developed headache and confusion a few
weeks before hospital admission. He presented with
enlarged bilateral cervical lymph nodes and left brachial
hemiparesis, and the head CT scan revealed a large thalamic
ischemia. The chest roentgenograms revealed several
cavitated lesions and diffuse infiltrates. A sputum smear
and the lymph node biopsy revealed acid-fast bacilli and
granulomas. Cerebral spinal fluid culture was negative for
M. tuberculosis. The CD
4
+ and CD
8
+ T-lymphocyte counts
were 514 cells/µL and 53 cells/µL, respectively.
Two of the patients presented with CD
4
+ T-lymphocyte
absolute counts below 300 cells/µL. A severe depletion of
the naïve, effector and memory subpopulations associated
with low numbers of CD
8
+ T-lymphocytes was observed in
all three patients with disseminated tuberculosis, coupled
with higher expression of CD
38
+ on the CD
8
+ T-lymphocytes
than in patients with pulmonary tuberculosis and in healthy
controls (Table 1).
Discussion
Several studies have demonstrated that tuberculosis
can exert a significant impact on lymphocyte counts
[3,4,6,9]. Swaminathan et al. compared healthy, tuberculin-
positive children to those with tuberculosis and found
reduced circulating CD4+ T-cell counts in the sick children,
which reversed after tuberculosis therapy [8].
In our cohort of 71 subjects, we observed a significant
reduction of T-lymphocyte counts in those with active
tuberculosis, when compared to healthy subjects [8]. This
difference was reversed after treatment, further supporting
the possibility that the disease itself might be responsible
for the observed T-cell depletion. In addition, a significant
decrease in absolute T-lymphocyte CD
4
+ counts, distributed
among naïve, effector and memory subpopulations, was
observed in patients with disseminated tuberculosis. The
significant CD
4 
and CD
8
 T-cell depletion in these three
patients resembles found in tuberculosis patients with AIDS
[10]. One study with 430 HIV-seronegative tuberculosis
patients conducted in Dakar, Senegal, associated low
peripheral CD
4
+ T-cell counts with severe disease, most
patients presenting extrapulmonary involvement, miliary
dissemination, oral candidiasis, and low level tuberculin
reaction [11].
It has been demonstrated that CD
8
+ T-lymphocytes
have cytolytic activity against the tuberculosis bacillus
[12], and their deficiency can result in susceptibility to
infection by M. tuberculosis [13]. However, the exact
function of these cells  in host  defense remains
controversial. Therefore, the understanding of the
activation status of such cells may help determine their
role in disease pathogenesis. We came across substantial
cellular activation in the three patients with disseminated
tuberculosis, significantly higher that the previously
observed cellular activation in patients with localized
disease [8].
These findings should impact the clinical and laboratory
evaluation of patients with disseminated tuberculosis. The
awareness of the profound depletion of T-cell
subpopulations associated with severe disease may
indicate misinterpreted idiopathic T-lymphocytopenia or
other cellular immunodeficiencies.
A laboratory follow-up is mandatory to distinguish
the effects of active disease from an underlying
immunodeficiency. The marked cellular activation seen
in these patients could mean that CD
38
 expression would
be a  useful  marker  of  tuberculosis  act ivi ty  and
prognosis.
Lymphocyte Depletion and Activation in Disseminated Tuberculosis
Table 1. Absolute CD
4
+ and CD
8
+ T-lymphocyte numbers and activation of CD
8
+ T-cells, measured by CD
38
 surface expression
Total CD
4
+ T- Total CD
8
 T Percentage of CD
38
+ in
lymphocytes, cells/µL lymphocytes, cells/µL CD8+ T-lymphocytes
Patient #1 186 152 54.88
Patient #2 59 43 70.78
Patient #3 514 53 58.27
Pulmonary TB*, median (IQR) 690  (526-857) 355  (240-482) 49.76  (34-60)
Treated TB*, median (IQR) 830 (738-969) 469 (323-534) 29.20  (22-38)
Healthy controls*, median (IQR) 1153 (997-1291) 830  (602-830) 39.04 (31-47)
IQR: Interquartile range. *: Reference values for pulmonary tuberculosis (TB); treated TB, and healthy controls were obtained from
Rodrigues et al. [8].
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